vs
Invivyd, Inc.（IVVD）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
Invivyd, Inc.的季度营收约是RIVERVIEW BANCORP INC的1.2倍（$17.2M vs $14.0M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -64.3%，领先74.1%），Invivyd, Inc.同比增速更快（24.5% vs 10.4%）
Invivyd, Inc.是一家处于临床阶段的生物制药企业，专注于研发可预防和治疗严重病毒性传染病的广谱中和抗体疗法，核心管线覆盖呼吸道合胞病毒等高负担呼吸道病原体，满足全球患者未被满足的医疗需求。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
IVVD vs RVSB — 直观对比
营收规模更大
IVVD
是对方的1.2倍
$14.0M
营收增速更快
IVVD
高出14.1%
10.4%
净利率更高
RVSB
高出74.1%
-64.3%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $17.2M | $14.0M |
| 净利润 | $-11.1M | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | -73.0% | 12.4% |
| 净利率 | -64.3% | 9.8% |
| 营收同比 | 24.5% | 10.4% |
| 净利润同比 | 40.0% | 11.8% |
| 每股收益（稀释后） | $0.02 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IVVDRVSB
| Q4 25 | $17.2M | $14.0M | ||
| Q3 25 | $13.1M | $13.6M | ||
| Q2 25 | $11.8M | $13.3M | ||
| Q1 25 | $11.3M | $12.9M | ||
| Q4 24 | $13.8M | $12.7M | ||
| Q3 24 | $9.3M | $12.8M | ||
| Q2 24 | $2.3M | $12.2M | ||
| Q1 24 | $0 | $9.0M |
净利润IVVDRVSB
| Q4 25 | $-11.1M | $1.4M | ||
| Q3 25 | $-10.5M | $1.1M | ||
| Q2 25 | $-14.7M | $1.2M | ||
| Q1 25 | $-16.3M | $1.1M | ||
| Q4 24 | $-18.4M | $1.2M | ||
| Q3 24 | $-60.7M | $1.6M | ||
| Q2 24 | $-47.2M | $966.0K | ||
| Q1 24 | $-43.5M | $-3.0M |
营业利润率IVVDRVSB
| Q4 25 | -73.0% | 12.4% | ||
| Q3 25 | -84.0% | 10.2% | ||
| Q2 25 | -127.8% | 11.7% | ||
| Q1 25 | -149.7% | 11.3% | ||
| Q4 24 | -139.1% | 12.4% | ||
| Q3 24 | -670.0% | 15.5% | ||
| Q2 24 | -2175.2% | 10.0% | ||
| Q1 24 | — | -47.5% |
净利率IVVDRVSB
| Q4 25 | -64.3% | 9.8% | ||
| Q3 25 | -79.7% | 8.1% | ||
| Q2 25 | -124.4% | 9.2% | ||
| Q1 25 | -144.1% | 8.9% | ||
| Q4 24 | -133.5% | 9.7% | ||
| Q3 24 | -653.1% | 12.2% | ||
| Q2 24 | -2086.9% | 7.9% | ||
| Q1 24 | — | -34.7% |
每股收益（稀释后）IVVDRVSB
| Q4 25 | $0.02 | $0.07 | ||
| Q3 25 | $-0.06 | $0.05 | ||
| Q2 25 | $-0.12 | $0.06 | ||
| Q1 25 | $-0.14 | $0.05 | ||
| Q4 24 | $-0.14 | $0.06 | ||
| Q3 24 | $-0.51 | $0.07 | ||
| Q2 24 | $-0.40 | $0.05 | ||
| Q1 24 | $-0.38 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $226.7M | $28.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $241.5M | $164.2M |
| 总资产 | $276.9M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IVVDRVSB
| Q4 25 | $226.7M | $28.6M | ||
| Q3 25 | $85.0M | $32.8M | ||
| Q2 25 | $34.9M | $34.2M | ||
| Q1 25 | $48.1M | $29.4M | ||
| Q4 24 | $69.3M | $25.3M | ||
| Q3 24 | $106.9M | $31.0M | ||
| Q2 24 | $147.9M | $27.8M | ||
| Q1 24 | $189.4M | $23.6M |
股东权益IVVDRVSB
| Q4 25 | $241.5M | $164.2M | ||
| Q3 25 | $93.1M | $163.5M | ||
| Q2 25 | $42.8M | $162.0M | ||
| Q1 25 | $54.1M | $160.0M | ||
| Q4 24 | $67.5M | $158.3M | ||
| Q3 24 | $83.2M | $160.8M | ||
| Q2 24 | $140.6M | $155.9M | ||
| Q1 24 | $178.5M | $155.6M |
总资产IVVDRVSB
| Q4 25 | $276.9M | $1.5B | ||
| Q3 25 | $139.2M | $1.5B | ||
| Q2 25 | $89.1M | $1.5B | ||
| Q1 25 | $103.7M | $1.5B | ||
| Q4 24 | $129.5M | $1.5B | ||
| Q3 24 | $161.9M | $1.5B | ||
| Q2 24 | $177.3M | $1.5B | ||
| Q1 24 | $215.5M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.5M | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-736.0K |
| 自由现金流率自由现金流/营收 | — | -5.2% |
| 资本支出强度资本支出/营收 | 0.0% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | — | $20.4M |
8季度趋势，按日历期对齐
经营现金流IVVDRVSB
| Q4 25 | $-15.5M | $-506.0K | ||
| Q3 25 | $-8.3M | $16.8M | ||
| Q2 25 | $-13.3M | $-697.0K | ||
| Q1 25 | $-21.1M | $8.3M | ||
| Q4 24 | $-37.6M | $2.2M | ||
| Q3 24 | $-41.1M | $764.0K | ||
| Q2 24 | $-41.6M | $5.4M | ||
| Q1 24 | $-50.2M | $12.8M |
自由现金流IVVDRVSB
| Q4 25 | — | $-736.0K | ||
| Q3 25 | — | $16.4M | ||
| Q2 25 | $-13.3M | $-773.0K | ||
| Q1 25 | $-21.3M | $5.6M | ||
| Q4 24 | $-37.6M | $1.9M | ||
| Q3 24 | $-41.1M | $-1.4M | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | $-50.4M | $7.1M |
自由现金流率IVVDRVSB
| Q4 25 | — | -5.2% | ||
| Q3 25 | — | 120.1% | ||
| Q2 25 | -112.9% | -5.8% | ||
| Q1 25 | -188.2% | 43.1% | ||
| Q4 24 | -272.2% | 15.0% | ||
| Q3 24 | -441.6% | -11.3% | ||
| Q2 24 | — | 43.7% | ||
| Q1 24 | — | 79.0% |
资本支出强度IVVDRVSB
| Q4 25 | 0.0% | 1.6% | ||
| Q3 25 | 0.0% | 2.9% | ||
| Q2 25 | 0.1% | 0.6% | ||
| Q1 25 | 1.3% | 21.0% | ||
| Q4 24 | 0.0% | 2.4% | ||
| Q3 24 | 0.1% | 17.3% | ||
| Q2 24 | 0.0% | 0.9% | ||
| Q1 24 | — | 62.0% |
现金转化率IVVDRVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
